Labiotech.eu

News and Trends 18 Feb 2015

#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!

WHO? 23andMe, founded in 2006, is the leading personal genetics company dedicated to helping people access, understand and benefit from the human genome. The vision for 23andMe is to personalize healthcare by making and supporting meaningful discoveries through genetic research. Photo credit: 23andMe WHAT? 23andMe, announced an agreement with Genentech, a member of the Swiss Roche Group, […]

February 18, 2015 - 2 minutesmins - By Marie Godar

News and Trends 18 Feb 2015

Highway to Brain

Researchers in Barcelona have developed a shuttle to transport drugs into the brain, running through the blood-brain barrier. If there is an irreplaceable organ, for the moment, that’s the brain. The gray matter is not only protected by the skull, but also by a barrier of cells that tightly regulates the transport of substances into this […]

February 18, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 16 Feb 2015

Great news for Great Britain’s synthetic biology

British government will inject the impressive amount of £40M to reinforce UK’s leading position in synthetic biology. UK Business Secretary Vince Cable has announced a £40M investment in UK synthetic biology at the Manchester Institute for Biotechnology. The majority of this investment, £32M, will be used to establish three new Synthetic Biology Research Centres at […]

February 16, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 14 Feb 2015

GlycoVaxyn: A new Gain for GSK’s Vaccines Business

GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological conjugation platform which may help it to develop a new generation of prophylactic vaccines against bacterial infections. GSK has today paid €167M to purchase the remaining stake in the company. GlycoVaxyn’s innovative biological conjugation platform originates enables the development of […]

February 14, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 12 Feb 2015

Neurostimulation, an Innovative Approach to Treat Heart Failure

The revolutionary Equilia system, meant to treat heart failure, has been successfully implanted for the first time in a clinical study . The developer of the system, Sorin Group, is an Italian medical device company, leader in the treatment of cardiovascular diseases. Heart failure is a chronic progressive disease in which the heart can no longer […]

February 12, 2015 - 2 minutesmins - By Lourdes Riquelme

News and Trends 11 Feb 2015

Hello Tomorrow Challenge, the startup competition with €100k to win!

The second edition of the Hello Tomorrow Challenge has been launched in December 2014. This is a great opportunity for startups, students and researchers to transform their innovative technologies into impactful products. The Challenge is open to innovative startups and research projects which: Are based on innovative technology Are under 2 years old (if incorporated) […]

February 11, 2015 - 1 minutemin - By Joachim Eeckhout

News and Trends 11 Feb 2015

AB Science: One step further towards a cure to Alzheimer’s disease

AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), today announced the successful completion of a futility analysis related to the masitinib phase 3 trial for the treatment of mild to moderate Alzheimer’s disease. Today, between 5 and 10 million people suffer from Alzheimer’s disease in the USA […]

February 11, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 10 Feb 2015

Is Pichia Pastoris the Best Protein Expression System?

Producing biologicals in living expression systems is a big challenge for the Biotech industry. World leaders in the field are betting on a new yield-enhancing expression technology using the yeast Pichia pastoris. Escherichia coli might be the first bacteria you think about when it comes to biotechnology. However, E. coli is not necessarily the best option to produce […]

February 10, 2015 - 4 minutesmins - By Lourdes Riquelme

News and Trends 7 Feb 2015

Fermentalg launch an Omega-3 enriched oil produced by microalgae

Six years after the creation of the company, Fermentalg, an industrial biotechnology company that specializes in the production of oils and proteins derived from microalgae, has received the European Novel Food authorization for its first product: DHA-enriched oil (Omega-3) for the vast human nutrition market. Obtaining this authorization means Fermentalg has achieved one of the priority […]

February 7, 2015 - 2 minutesmins - By Joachim Eeckhout

News and Trends 6 Feb 2015

2014, the Biggest Year Ever for European Biotech IPOs

There is no need to say it: biotechnology is the latest trend. A worldwide bio-boom has shaken stock markets throughout 2014. For European start-ups, last year represented a remarkable step forward as 15 companies went public and raised €719.8M in total, as Biocom’s last report states. Let me present you a review summering the major […]

February 6, 2015 - 3 minutesmins - By Lourdes Riquelme

News and Trends 4 Feb 2015

And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

Moderna is the Biotech company that raised the biggest VC round ever ($450M) and which signs deals almost every week. It signed a $50M deal with Merck two weeks ago, and now signs a strategic partnership with prestigious Institut Pasteur from Paris through its new Venture Valera. Moderna is developing a proprietary mRNA therapeutics platform. Instead […]

February 4, 2015 - 2 minutesmins - By Philip Hemme

News and Trends 3 Feb 2015

AYOXXA raises its sights with a new agreement to develop ophthalmic diagnostic tools

New agreement was signed between AYOXXA, an international biotech company with headquarters in Cologne, and the Singapore Eye Research Institute (SERI), one of the leading international eye research institutes. AYOXXA and SERI will work together on validating the company’s multiplexing technology platform for protein biomarker detection, as part of an expanded collaboration for developing ophthalmic […]

February 3, 2015 - 3 minutesmins - By Lourdes Riquelme

Resources

Categories

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

#BioFigures: 3,000 whole genomes sequenced to fight Parkinson!

Highway to Brain

Great news for Great Britain’s synthetic biology

GlycoVaxyn: A new Gain for GSK’s Vaccines Business

Neurostimulation, an Innovative Approach to Treat Heart Failure

Hello Tomorrow Challenge, the startup competition with €100k to win!

AB Science: One step further towards a cure to Alzheimer’s disease

Is Pichia Pastoris the Best Protein Expression System?

Fermentalg launch an Omega-3 enriched oil produced by microalgae

2014, the Biggest Year Ever for European Biotech IPOs

And now, Moderna signs a strategic partnership with prestigious Institut Pasteur

AYOXXA raises its sights with a new agreement to develop ophthalmic diagnostic tools

Subscribe to our newsletter to get the latest biotech news!

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Promising cure for COPD: Is a breakthrough treatment within reach?

12 biotech unicorns revolutionizing the future of healthcare

Grab your free report on 3D organoids and explore their future potential

RNA editing in humans: the race begins with first successful trial

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!